Thursday, March 26, 2020

Cipla gets USFDA nod for generic acid reflux drug

Cipla gets USFDA nod for generic acid reflux drug Cipla is the first company to file for the 10mg strength, it added. The product is a generic version of AstraZeneca Pharmaceutical#39;s Nexium. It is indicated for the treatment of gastroesophageal reflux disease, risk reduction of NSAID-associated gastric ulcer, among others, Cipla said.

from Moneycontrol Business News https://ift.tt/2UBKnkF
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...